» Articles » PMID: 2514622

BRO Beta-lactamases of Branhamella Catarrhalis and Moraxella Subgenus Moraxella, Including Evidence for Chromosomal Beta-lactamase Transfer by Conjugation in B. Catarrhalis, M. Nonliquefaciens, and M. Lacunata

Overview
Specialty Pharmacology
Date 1989 Nov 1
PMID 2514622
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Two closely related beta-lactamases, BRO-1 and BRO-2 (formerly called Ravasio and 1908), are found in Moraxella (Branhamella) catarrhalis. We screened strains of B. catarrhalis recovered in the United States since 1952 and identified the first beta-lactamase-positive isolate in August 1976. The prevalence of the enzymes among 394 clinical isolates from one Texas hospital has averaged 75% since testing began in 1983. Screening of isolates of Moraxella subgenus Moraxella revealed the BRO enzymes in two other human respiratory tract species, M. lacunata and M. nonliquefaciens, beginning in 1978. A different beta-lactamase with a pI of 6.4 predominated in other species of subgenus Moraxella. BRO-2 had a different isoelectric focusing pattern and was produced in lesser amounts than BRO-1, but the two enzymes were indistinguishable by substrate or inhibitor profile. BRO enzymes from B. catarrhalis, M. nonliquefaciens, and M. lacunata could be transferred by conjugation and, for B. catarrhalis, also by transformation to B. catarrhalis. Plasmid bands were demonstrated in 90% of M. nonliquefaciens and in one previously reported strain of B. catarrhalis, but no change in plasmid profiles was seen in beta-lactamase-positive recombinants, supporting previous studies that suggested the beta-lactamase genes are chromosomal.

Citing Articles

from the Human Nose Inhibit Colonization with a Secreted Peptidoglycan Endopeptidase.

Stubbendieck R, Dissanayake E, Burnham P, Zelasko S, Temkin M, Wisdorf S mBio. 2023; 14(2):e0046423.

PMID: 37010413 PMC: 10128031. DOI: 10.1128/mbio.00464-23.


The characterization of carried in the general population.

Morris D, Osman K, Cleary D, Clarke S Microb Genom. 2022; 8(5).

PMID: 35639578 PMC: 9465073. DOI: 10.1099/mgen.0.000820.


Bacteremia due to Moraxella osloensis: a case report and literature review.

Maruyama Y, Shigemura T, Aoyama K, Nagano N, Nakazawa Y Braz J Infect Dis. 2018; 22(1):60-62.

PMID: 29409692 PMC: 9425674. DOI: 10.1016/j.bjid.2017.10.008.


A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Perez A, Murphy T Hum Vaccin Immunother. 2017; 13(10):2322-2331.

PMID: 28853985 PMC: 5647992. DOI: 10.1080/21645515.2017.1356951.


Community-Acquired Moraxella catarrhalis Bacteremic Pneumonia: Two Case Reports and Review of the Literature.

Ariza-Prota M, Pando-Sandoval A, Garcia-Clemente M, Fole-Vazquez D, Casan P Case Rep Pulmonol. 2016; 2016:5134969.

PMID: 26989548 PMC: 4775775. DOI: 10.1155/2016/5134969.


References
1.
Kirven L, Thornsberry C . Transfer of beta-lactamase genes of Neisseria gonorrhoeae by conjugation. Antimicrob Agents Chemother. 1977; 11(6):1004-6. PMC: 352118. DOI: 10.1128/AAC.11.6.1004. View

2.
Bush K . Characterization of beta-lactamases. Antimicrob Agents Chemother. 1989; 33(3):259-63. PMC: 171476. DOI: 10.1128/AAC.33.3.259. View

3.
MOSS C, Wallace P, Hollis D, Weaver R . Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis. J Clin Microbiol. 1988; 26(3):484-92. PMC: 266318. DOI: 10.1128/jcm.26.3.484-492.1988. View

4.
Stobberingh E, van Eck H, Houben A, van Boven C . Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis. Drugs. 1986; 31 Suppl 3:23-7. DOI: 10.2165/00003495-198600313-00007. View

5.
Eisenstein B, Sox T, Biswas G, Blackman E, Sparling P . Conjugal transfer of the gonococcal penicillinase plasmid. Science. 1977; 195(4282):998-1000. DOI: 10.1126/science.402693. View